Suppr超能文献

一种与已知关注变异株存在共同突变的新型严重急性呼吸综合征冠状病毒2(SARS-CoV-2)谱系被自动化序列储存库质量控制拒收。

A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control.

作者信息

Thornlow Bryan, Hinrichs Angie S, Jain Miten, Dhillon Namrita, La Scott, Kapp Joshua D, Anigbogu Ikenna, Cassatt-Johnstone Molly, McBroome Jakob, Haeussler Maximilian, Turakhia Yatish, Chang Terren, Olsen Hugh E, Sanford Jeremy, Stone Michael, Vaske Olena, Bjork Isabel, Akeson Mark, Shapiro Beth, Haussler David, Kilpatrick A Marm, Corbett-Detig Russell

机构信息

Department of Biomolecular Engineering, University of California, Santa Cruz.

Genomics Institute, University of California, Santa Cruz.

出版信息

bioRxiv. 2021 Apr 6:2021.04.05.438352. doi: 10.1101/2021.04.05.438352.

Abstract

We report a SARS-CoV-2 lineage that shares N501Y, P681H, and other mutations with known variants of concern, such as B.1.1.7. This lineage, which we refer to as B.1.x (COG-UK sometimes references similar samples as B.1.324.1), is present in at least 20 states across the USA and in at least six countries. However, a large deletion causes the sequence to be automatically rejected from repositories, suggesting that the frequency of this new lineage is underestimated using public data. Recent dynamics based on 339 samples obtained in Santa Cruz County, CA, USA suggest that B.1.x may be increasing in frequency at a rate similar to that of B.1.1.7 in Southern California. At present the functional differences between this variant B.1.x and other circulating SARS-CoV-2 variants are unknown, and further studies on secondary attack rates, viral loads, immune evasion and/or disease severity are needed to determine if it poses a public health concern. Nonetheless, given what is known from well-studied circulating variants of concern, it seems unlikely that the lineage could pose larger concerns for human health than many already globally distributed lineages. Our work highlights a need for rapid turnaround time from sequence generation to submission and improved sequence quality control that removes submission bias. We identify promising paths toward this goal.

摘要

我们报告了一种新冠病毒谱系,它与已知的关注变体(如B.1.1.7)共享N501Y、P681H及其他突变。这种谱系,我们称之为B.1.x(COG-UK有时将类似样本称为B.1.324.1),在美国至少20个州以及至少六个国家存在。然而,一个大的缺失导致该序列被数据库自动拒收,这表明利用公开数据对这种新谱系的频率估计不足。基于在美国加利福尼亚州圣克鲁斯县获得的339个样本的近期动态表明,B.1.x的频率可能正以与南加州B.1.1.7相似的速度增加。目前,这种B.1.x变体与其他正在传播的新冠病毒变体之间的功能差异尚不清楚,需要进一步研究二代发病率、病毒载量、免疫逃逸和/或疾病严重程度,以确定它是否构成公共卫生问题。尽管如此,根据对充分研究的关注传播变体的了解,该谱系对人类健康造成的担忧似乎不太可能超过许多已经在全球传播的谱系。我们的工作强调了从序列生成到提交需要快速周转时间,以及改进序列质量控制以消除提交偏差的必要性。我们确定了实现这一目标的可行途径。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/679e/8043452/af1ceaaa69c8/nihpp-2021.04.05.438352-f0001.jpg

相似文献

3
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Adapting Safety Plans for Autistic Adults with Involvement from the Autism Community.
Autism Adulthood. 2025 May 28;7(3):293-302. doi: 10.1089/aut.2023.0124. eCollection 2025 Jun.
7
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
10
Automated monitoring compared to standard care for the early detection of sepsis in critically ill patients.
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012404. doi: 10.1002/14651858.CD012404.pub2.

引用本文的文献

1
Spread of endemic SARS-CoV-2 lineages in Russia before April 2021.
PLoS One. 2022 Jul 20;17(7):e0270717. doi: 10.1371/journal.pone.0270717. eCollection 2022.

本文引用的文献

2
A Unique SARS-CoV-2 Spike Protein P681H Variant Detected in Israel.
Vaccines (Basel). 2021 Jun 8;9(6):616. doi: 10.3390/vaccines9060616.
3
Rapid detection of inter-clade recombination in SARS-CoV-2 with Bolotie.
Genetics. 2021 Jul 14;218(3). doi: 10.1093/genetics/iyab074.
4
Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic.
Nat Genet. 2021 Jun;53(6):809-816. doi: 10.1038/s41588-021-00862-7. Epub 2021 May 10.
5
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
Cell. 2021 Apr 29;184(9):2384-2393.e12. doi: 10.1016/j.cell.2021.03.036. Epub 2021 Mar 20.
7
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies.
Nat Med. 2021 May;27(5):917-924. doi: 10.1038/s41591-021-01318-5. Epub 2021 Mar 26.
8
Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England.
Nature. 2021 May;593(7858):266-269. doi: 10.1038/s41586-021-03470-x. Epub 2021 Mar 25.
9
Lost in deletion: The enigmatic ORF8 protein of SARS-CoV-2.
Biochem Biophys Res Commun. 2021 Jan 29;538:116-124. doi: 10.1016/j.bbrc.2020.10.045. Epub 2020 Oct 21.
10
Genomic Evidence of SARS-CoV-2 Reinfection Involving E484K Spike Mutation, Brazil.
Emerg Infect Dis. 2021 May;27(5):1522-1524. doi: 10.3201/eid2705.210191. Epub 2021 Feb 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验